We believe that with the current technology society is on the verge of creating a bio-based economy. EV Biotech will evolve the chemical feedstock market by revolutionizing the methods of microbial cell factory strain engineering, hereby shifting the chemical market from petrochemical-based to biological-based chemical production.
A revolutionary step for a sustainable future.
Our approach
EV Biotech uses computational modelling to predict the optimal host organism together with a set of optimized genetic modifications, to maximize yields of the compound of interest. This significantly minimizes development time compared to a traditional trial-and-error based approach.
Analysis of the computational models is used to generate an optimal genetic blueprint, ready to be implemented into the micro-organism of choice.
A prototype microbial cell factory (MCB) is created using the genetic modifications suggested by the model. The experimental feedback generated during the trials is used to improve and correct the initial model, speeding up the MCB optimization and upscaling process.
EV Biotech is an interdisciplinary and dynamic start-up based in Groningen, the Netherlands, founded by a team of three young enthusiastic scientists. Our mission is biological production of high-value chemical compounds for Flavors & Fragrances, Biomaterials, Agriculture and Pharmaceutical markets. Our goal is to steer the chemical industry from unsustainable and oil-based sources to microbial production using a combination of the cutting edge techniques in Microbiology, Genetic Engineering and Systems Biology.
Prof. dr. Ben Feringa, Nobel Laureate Chemistry 2016“Bacterial engineering has bright prospects for sustainable chemical products. I will be following EV Biotech closely”
Prof. dr Aard Groen Professor of Entrepreneurship at the University of Groningen and the University of Twente“After graduating from EIT-health Venturelab program, EV-biotech lead by Linda Dijkshoorn successfully develops into a competent entrepreneurial team ready for the high-tech and high-growth biotechnology field. I have high expectations about their coming success”
Dr. Ton Vries, Managing Director MercachemSyncom and Managing Director Groningen Campus“EV Biotech develops alternative and complementary technologies for chemical production using bacterial engineering. I am very positive about the technology and it’s potential”
EV Biotech is currently developing a number Proof of Concept microbial cell factories for the production of high-value molecules and their precursors. Our current interests include the Biomaterials and Flavour and Fragrance markets.